COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 1184: Articles 11831-11840  | Next

Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
Jackson, H., Rivero Calle, I., Broderick, C., Habgood-Coote, D., D'Souza, G., Nichols, S., Gomez Rial, J., Rivero-Velasco, C., Rodriguez-Nunez, N., Barbeito-Castineiras, G., Perez-Freixo, H., Barreiro-de Acosta, M., Cunnington, A., Herberg, J., Wright, V., Gomez-Carballa, A., Salas, A., Levin, M., Martinon-Torres, F., Kaforou, M., PERFORM consortium, , GEN-COVID study group
10.1101/2021.09.16.21263170 — Posted: 2021-09-21
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
Maskin, L. P., Bonelli, I., Olarte, G. L., Palizas, F., Velo, A. E., Lurbet, M. F., Lovazzano, P., Kotsias, S., Attie, S., Lopez Saubidet, I., Baredes, N. D., Setten, M., Rodriguez, P. O.
10.1101/2021.09.15.21263597 — Posted: 2021-09-21
Planning and Conducting an Online Conference at the time of COVID-19: Lessons Learned from EGREPA 2021
Bentlage, E., Roekens, L., Bussmann, L., Brach, M.
10.1101/2021.09.19.460976 — Posted: 2021-09-20
Masking significantly reduces, but does not eliminate COVID-19 infection in a spatial agent-based simulation of a University dormitory floor
McPeck, R., Magori, K.
10.1101/2021.09.13.21263458 — Posted: 2021-09-20
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial
Innis, B. L., Mercer, L. D., White, J. A., Scharf, R., Hjorth, R., Lamola, S., Raghunandan, R., Lal, M., McLellan, J. S., Hsieh, C.-L., Pitisuttithum, P., Luvira, V., Muangnoicharoen, S., Lawpoolsri, S., Sivakorn, C., Phumratanaprapin, W., Kamolratanakul, S., Phonrat, B., Sabmee, Y., Thantamnu, N., Wirachwong, P., Poopipatpol, K., Surichan, S., Prangpratanporn, S., Kaweepornpoj, R., Theerasurakarn, S., Narakorn, P., Singchareon, R., Suthepakul, N., Puksuriwong, S., Vilasmongkolchai, T., Gagnon, L., Tran, S., Khan, S., Krammer, F., Mena, I., Garcia-Sastre, A., Sun, W., Liu, Y., McCroskery, S.
10.1101/2021.09.17.21263758 — Posted: 2021-09-20
EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL
Fedrizzi, E. N., Girondi, J. B. R., Sakae, T. M., Steffens, S. M., Silvestrin, A. N. d. S., Claro, G. S., Iskenderian, H. A., Hillmann, B., Gervasi, L. C., Trapani, A., Rodrigues, P. d. A., Vieira, A. d. S., Evaristo, S. M., Tristao, F. R., Muniz, F. d. S., Nunes, M. V., Beatriz, N. Z., Elpo, J., Tiedje, A., Siqueira, L. S., Sens, M., Nandi, V., Pereira, J. G., Henrique, G. C., de Carvalho, A. P. F., de Morais, R. C. P., de Cristo, G. G., Hochsprung, M. E., Morais, A. C., Centenaro, R., Garcia, A., Silva, B. H., Ouriques Neta, E. L., Ferreira, M. E. A., Hames, M. E., Gubert, M. E. P., Calegari, M. R., Martins, M. L. B., Oliveira, G. S., Marian, M. d. S., Sousa, L. S., Fedrizzi, M. d. S.
10.1101/2021.09.14.21263598 — Posted: 2021-09-20 Discussion: Onsite | Offsite
Correlates of COVID-19 vaccination status among college students
Nicolo, M., Kawaguchi, E., Ghanem-Uzqueda, A., Kim, A. E., Soto, D., Deva, S., Shanker, K. R., Rogers, C., Lee, R., Gilliland, F., Klausner, J., Kovacs, A., Conti, D. V., Hu, H., Unger, J. B.
10.1101/2021.09.15.21263654 — Posted: 2021-09-20
The supramolecular organization of SARS-CoV and SARS-CoV-2 virions revealed by coarse-grained models of intact virus envelopes
Wang, B., Zhong, C., Tieleman, D. P.
10.1101/2021.09.16.460716 — Posted: 2021-09-20
SARS-CoV-2 variants in Paraguay: Detection and surveillance with a readily modifiable, multiplex real-time RT-PCR
Martinez, M., Nguyen, P.-V., Su, M., Cardozo, F., Valenzuela, A., Franco, L., Galeano, M. E., Rojas, L. E., Diaz Acosta, C. C., Fernandez, J., Ortiz, J., del Puerto, F., Mendoza, L., Nara, E., Rojas, A., Waggoner, J.
10.1101/2021.09.15.21263618 — Posted: 2021-09-20
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
Sabatino, J. J., Mittl, K., Rowles, W., Mcpolin, K., Rajan, J., Zamecnik, C. R., Dandekar, R., Alvarenga, B., Loudermilk, R. P., Gerungan, C., spencer, C., Sagan, S., Augusto, D., Alexander, J., Hollenbach, J. A., Wilson, M. R., Zamvil, S., Bove, R.
10.1101/2021.09.10.21262933 — Posted: 2021-09-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).